Carotid artery stent survey.
This article was originally published in The Gray Sheet
Executive Summary
Data from 24 international interventional medical centers on 2,591 carotid artery stenting procedures show a technical success rate of about 98% and a 5% complication rate. The survey, conducted by Michael Wholey, MD, Louisiana State University, New Orleans, was presented March 2 at the annual meeting of the Society of Cardiovascular and Interventional Radiology in San Francisco. Results show a restenosis rate of 3% after six months and complication rates comparable to endarterectomy, the current standard of care for preventing stroke caused by carotid artery stenosis. Boston Scientific, Johnson & Johnson's Cordis, Guidant and Endotex are among companies developing products for use in carotid artery stenting...
You may also be interested in...
Simplified Clinical Trial Transparency Rules To Go Live In The EU In June
A new version of the EU Clinical Trials Information System’s public portal will integrate the functionalities of the streamlined transparency rules.
Top-Selling Drugs 2023: Pharma’s $60bn COVID-19 Cliff
Pfizer/BioNTech’s COVID-19 vaccine Comirnaty toppled after recording the highest ever annual sales for a pharmaceutical in 2022, while Novo Nordisk’s Ozempic climbed rapidly. But Merck & Co’s immuno-oncology blockbuster Keytruda was secure in the number one spot in 2023 as COVID-19 receded.
Changes To EU Pharma Reform: More Questions Than Answers?
In the first of a series of articles on the future direction of the EU pharmaceutical reform proposals, the Pink Sheet looks at the new uncertainties created for the drug industry after the European Parliament voted through a series of amendments in the area of regulatory data protection.